Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Tissue and vessel level refers to a physiological and anatomical scale of biological organization rather than a specific molecular target such as a receptor, enzyme, or ion channel. In the fields of pharmacology and systems biology, this level of analysis describes the movement of therapeutic agents through the circulatory system (vessels) and their subsequent distribution into the extravascular space of various organs (tissues). It encompasses complex processes including bulk flow, capillary filtration, and diffusion through the interstitial matrix, which are fundamental to Physiologically Based Pharmacokinetic (PBPK) modeling. Because it represents a structural hierarchy of the body, it does not possess a unique molecular structure or a specific biochemical mechanism of action that can be targeted by a drug. Consequently, while critical for understanding drug disposition and efficacy, it is classified as a level of physiological observation rather than a discrete therapeutic target.
Not applicable as this is a physiological level of organization, not a molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tissue and vessel level.